Microsoft (MSFT)-backed OpenAI's latest venture, Merge Labs, is looking to develop a novel gene therapy approach targeting brain cells. Read more here.

The brain chip company that has drawn interest from Sam Altman and his artificial intelligence business OpenAI is exploring ...

OpenAI's CEO is reportedly raising funds for a brain implant startup that would directly compete with Elon Musk's Neuralink. He'll have his work cut out for him.

OpenAI CEO Sam Altman is reportedly working to launch a new brain-to-computer interface company, Merge Labs, with early ...

The Boston startup, which is developing software for autonomous flying, plans to merge with a blank-check company early next ...

The OpenAI CEO is planning to back new a brain-implant startup, Merge Labs, according to the Financial Times, citing ...

Who doesn't know OpenAI CEO Sam Altman? Sam Altman, who is in the headlines for ChatGPT, is once again in the news, but this ...

The feud between Sam Altman and onetime cofounder Elon Musk may soon escalate with OpenAI's reported investment in a ...

OpenAI is reportedly discussing a potential investment in a new startup that aims to compete with Elon Musk’s brain implant ...

OpenAI CEO Sam Altman is in talks to co-found Merge Labs, a potential $850M brain–computer interface startup rivaling Elon ...

The new venture will go head-to-head with Elon Musk’s brain chip startup Neuralink. Altman is reportedly betting that AI can ...

OpenAI plans to back a competitor to Elon Musk’s Neuralink in the brain-computer interface market, the Financial Times reported. Merge Labs aims to raise $250 million for a valuation of $850 million, ...